The Centers for Medicare and Medicaid Services has decided to abandon its controversial Medicare Part B drug demonstration project in the face of likely opposition from President-elect Trump’s selection for HHS secretary, Rep. Tom Price, R-Ga.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?